Good Cholesterol Gone Bad? HDL and COVID-19

Area of Science:

• Cardiovascular biology
• Virology
• Immunology

Background:

• COVID-19, caused by SARS-CoV-2, shows inverse correlation between HDL levels and disease severity.
• Low HDL levels are linked to increased risk of severe COVID-19 outcomes.
• HDL's interaction with SARS-CoV-2 spike protein and ACE2 receptor is complex, with studies showing both facilitation and suppression of infection.

Purpose of the Study:

• To review the multifaceted role of HDL and SR-B1 in SARS-CoV-2 infection and COVID-19.
• To explore recent advancements in understanding HDL's structure, properties, and function during SARS-CoV-2 infection.

Main Methods:

• Literature review of existing studies on HDL, SR-B1, and SARS-CoV-2.
• Analysis of the interplay between HDL, SR-B1, and viral entry mechanisms.
• Synthesis of current knowledge on HDL's impact on COVID-19 pathogenesis.

Main Results:

• HDL's effect on SARS-CoV-2 infection is context-dependent, influenced by HDL concentration and SR-B1 expression.
• HDL can facilitate viral entry by binding to the spike protein and promoting interaction with ACE2 under specific conditions.
• Conversely, HDL has also been shown to suppress SARS-CoV-2 infection, with SR-B1 mediating this effect.

Conclusions:

• HDL and SR-B1 are critical mediators in cholesterol metabolism and play a significant, complex role in COVID-19.
• Understanding HDL's dual role in viral infection is crucial for developing therapeutic strategies against SARS-CoV-2.
• Further research into HDL structure and function during infection is warranted to elucidate its precise impact on COVID-19.